Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Bexarotene

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCDERM1059

06/01/2011

Phase IV Randomized Study of Two Dose Levels of Targretin Capsules in Patients with Refractory Cutaneous T-Cell Lymphoma